Annovis Bio, Inc. — Director's Dealing 2021

Jul 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Annovis Bio, Inc. (ANVS)
CIK: 0001477845
Period of Report: 2021-07-07

Reporting Person: McGroarty Jeffrey Brian (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-07	Stock Option (right to buy)	$102.85	A	14000	Acquired	2031-07-07	Common Stock (14000)	Direct

Footnotes

F1: The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to be employed by the issuer on the applicable vesting date.